These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25817520)

  • 1. Frequency and profile of Parkinson's disease prodromi in patients with malignant melanoma.
    Walter U; Heilmann E; Voss J; Riedel K; Zhivov A; Schäd SG; Gross GE; Benecke R; Trcka J
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):302-10. PubMed ID: 25817520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson's disease.
    Busse K; Heilmann R; Kleinschmidt S; Abu-Mugheisib M; Höppner J; Wunderlich C; Gemende I; Kaulitz L; Wolters A; Benecke R; Walter U
    J Neurol Neurosurg Psychiatry; 2012 Apr; 83(4):441-7. PubMed ID: 22362921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midbrain hyperechogenicity, hyposmia, mild parkinsonian signs and risk for incident Parkinson's disease over 10 years: A prospective population-based study.
    Mahlknecht P; Stockner H; Marini K; Gasperi A; Djamshidian A; Willeit P; Kiechl S; Willeit J; Rungger G; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2020 Jan; 70():51-54. PubMed ID: 31864071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.
    Walter U; Heilmann R; Kaulitz L; Just T; Krause BJ; Benecke R; Höppner J
    J Neural Transm (Vienna); 2015 Jun; 122(6):789-97. PubMed ID: 25217967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic value of combined assessment of olfaction and sustantia nigra hyperechogenicity for Parkinson's disease.
    López Hernández N; García Escrivá A; Shalabi Benavent M
    Neurologia; 2015 Oct; 30(8):496-501. PubMed ID: 24839905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.
    Hoeppner J; Prudente-Morrissey L; Herpertz SC; Benecke R; Walter U
    Eur Arch Psychiatry Clin Neurosci; 2009 Mar; 259(2):92-7. PubMed ID: 18806917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-motor features of Parkinson's disease in a nested case-control study of US men.
    Hughes KC; Gao X; Baker JM; Stephen C; Kim IY; Valeri L; Schwarzschild MA; Ascherio A
    J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1288-1295. PubMed ID: 30076266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors for mild parkinsonian signs: a prospective population-based study.
    Mahlknecht P; Kiechl S; Stockner H; Willeit J; Gasperi A; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2015 Mar; 21(3):321-4. PubMed ID: 25585991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substantia nigra echogenicity correlated with clinical features of Parkinson's disease.
    Zhou HY; Sun Q; Tan YY; Hu YY; Zhan WW; Li DH; Wang Y; Xiao Q; Liu J; Chen SD
    Parkinsonism Relat Disord; 2016 Mar; 24():28-33. PubMed ID: 26842545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential impact of self-perceived prodromal symptoms on the early diagnosis of Parkinson's disease.
    Walter U; Kleinschmidt S; Rimmele F; Wunderlich C; Gemende I; Benecke R; Busse K
    J Neurol; 2013 Dec; 260(12):3077-85. PubMed ID: 24085348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging abnormalities in individuals exhibiting Parkinson's disease risk markers.
    Heldmann M; Heeren J; Klein C; Rauch L; Hagenah J; Münte TF; Kasten M; Brüggemann N
    Mov Disord; 2018 Sep; 33(9):1412-1422. PubMed ID: 29756356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study.
    Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D
    Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sonography for diagnosis of Parkinson disease-from theory to practice: a study on 300 participants.
    Alonso-Cánovas A; López-Sendón JL; Buisán J; deFelipe-Mimbrera A; Guillán M; García-Barragán N; Corral I; Matute-Lozano MC; Masjuan J; Martínez-Castrillo JC; Walter U
    J Ultrasound Med; 2014 Dec; 33(12):2069-74. PubMed ID: 25425362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population.
    Liepelt I; Behnke S; Schweitzer K; Wolf B; Godau J; Wollenweber F; Dillmann U; Gaenslen A; Di Santo A; Maetzler W; Berg D
    Neurobiol Aging; 2011 Sep; 32(9):1599-606. PubMed ID: 19897277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
    Toomsoo T; Liepelt-Scarfone I; Kerner R; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
    J Ultrasound Med; 2016 Jan; 35(1):17-23. PubMed ID: 26589647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial sonography in idiopathic REM sleep behavior disorder and multiple system atrophy.
    Li X; Xue S; Jia S; Zhou Z; Qiao Y; Hou C; Wei K; Zheng W; Rong P; Jiao J
    Psychiatry Clin Neurosci; 2017 Apr; 71(4):238-246. PubMed ID: 27898200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.